Invention Grant
- Patent Title: DHEA bioadhesive controlled release gel
- Patent Title (中): DHEA生物粘附控制释放凝胶
-
Application No.: US14688603Application Date: 2015-04-16
-
Publication No.: US09320744B2Publication Date: 2016-04-26
- Inventor: Michael S. Riepl
- Applicant: DHEA LLC
- Applicant Address: US ND Bismarck
- Assignee: DHEA LLC
- Current Assignee: DHEA LLC
- Current Assignee Address: US ND Bismarck
- Agent Richard C. Litman
- Main IPC: A61K31/5685
- IPC: A61K31/5685 ; A61K9/00 ; A61K31/355 ; A61K9/06 ; A61K47/32 ; A61K31/00 ; A61K31/566

Abstract:
The DHEA bioadhesive controlled release gel includes DHEA mixed in a polymeric gel for the purpose of treating atrophic vaginitis, vaginal dryness, dyspareunia, itching, burning, irritation, increase in pH and decreased vaginal flora. The gel adheres to vaginal tissue and protects the DHEA from systemic absorption, which prevents leakage, loss of DHEA, and elevated levels of systemic DHEA. The gel is configured to slowly erode over time so as to deliver a predetermined dose of DHEA to vaginal tissue and thereby promote local intracellular conversion to estrogens, androgens and progesterone so that normal levels of fluid in the vagina is produced. The gel also acts as a moisturizer. An adjustable applicator may also be provided to insure proper placement and dose of the DHEA.
Public/Granted literature
- US20150297510A1 DHEA BIOADHESIVE CONTROLLED RELEASE GEL Public/Granted day:2015-10-22
Information query
IPC分类: